Skip to main content

Table 3 Between drug effect on RV volumetric parameters showing a significant difference in RV ESV and RVEF favouring deferiprone.

From: Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload

  Treatment effect  
  Deferiprone-Deferoxamine  
  Mean 95% CI p
EDV -1.21 -4.44 2.03 0.47
ESV -1.82 -3.27 -0.37 0.014
SV 0.64 -2.02 3.31 0.64
EF 1.16 0.30 2.01 0.008